Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Farmers Insurance
Boehringer Ingelheim
US Army
Healthtrust
Baxter
Teva
McKinsey
Medtronic
McKesson

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,062,264

« Back to Dashboard

Summary for Patent: 8,062,264
Title:Fluid dispensing device
Abstract: A fluid dispensing device for dispensing a fluid product having a dispensing member mounted for movement along an axis X-X from a first position to a second position which causes a dose of a fluid product to be dispensed, and a finger-operable actuator member movable in an actuating direction generally transverse to the axis to cause at least one cam surface thereof to cam the dispensing member from the first position to the second position. The at least one cam surface has a commitment section, oriented at a first angle to the axis selected such that a minimum actuating force is required to be applied to the actuator member to cause the at least one cam follower surface to ride over the commitment section onto the drive section. The commitment section of the cam surface is arcuate.
Inventor(s): Godfrey; James William (Ware, GB), Hedley; Mark Graham (Ware, GB)
Assignee: Glaxo Group Limited (Greenford, Middlesex, GB)
Application Number:11/911,060
Patent Claim Types:
see list of patent claims
Device; Formulation;

Drugs Protected by US Patent 8,062,264

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Glaxosmithkline Cons FLONASE SENSIMIST ALLERGY RELIEF fluticasone furoate SPRAY, METERED;NASAL 022051-002 Aug 2, 2016 OTC Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,062,264

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0507224.4Apr 09, 2005
PCT Information
PCT FiledApril 05, 2006PCT Application Number:PCT/GB2006/001264
PCT Publication Date:October 19, 2006PCT Publication Number: WO2006/109021

International Patents Family Members for US Patent 8,062,264

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 101528357 ➤ Subscribe
Cyprus 1111247 ➤ Subscribe
Germany 602006015935 ➤ Subscribe
Denmark 1868731 ➤ Subscribe
European Patent Office 1868731 ➤ Subscribe
Spain 2347976 ➤ Subscribe
United Kingdom 0507224 ➤ Subscribe
Hong Kong 1115834 ➤ Subscribe
Japan 2008538706 ➤ Subscribe
Israel 186368 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Novartis
Colorcon
Covington
Harvard Business School
US Army
Argus Health
Fish and Richardson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot